Free Trial

Illumina (ILMN) Competitors

Illumina logo
$96.68 -2.64 (-2.65%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Illumina vs. Its Competitors

Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Agilent Technologies has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500.

Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$6.51B5.43$1.29B$4.2629.26
Illumina$4.37B3.40-$1.22B$7.9012.24

Illumina has a net margin of 29.36% compared to Agilent Technologies' net margin of 17.97%. Illumina's return on equity of 28.93% beat Agilent Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Agilent Technologies17.97% 25.51% 12.94%
Illumina 29.36%28.93%10.74%

Agilent Technologies presently has a consensus price target of $139.25, indicating a potential upside of 11.71%. Illumina has a consensus price target of $123.06, indicating a potential upside of 27.29%. Given Illumina's higher possible upside, analysts plainly believe Illumina is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Illumina
2 Sell rating(s)
11 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.21

In the previous week, Agilent Technologies had 12 more articles in the media than Illumina. MarketBeat recorded 27 mentions for Agilent Technologies and 15 mentions for Illumina. Illumina's average media sentiment score of 1.43 beat Agilent Technologies' score of 1.38 indicating that Illumina is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
22 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Illumina
12 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.4% of Illumina shares are held by institutional investors. 2.6% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Illumina beats Agilent Technologies on 8 of the 15 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ILMN vs. The Competition

MetricIlluminaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$14.87B$3.15B$5.81B$10.17B
Dividend YieldN/A2.32%5.69%4.61%
P/E Ratio12.2421.3774.6226.02
Price / Sales3.40294.32466.0690.52
Price / Cash20.3645.3337.0859.91
Price / Book6.469.6212.166.30
Net Income-$1.22B-$53.29M$3.29B$270.86M
7 Day Performance-2.28%0.35%1.07%3.41%
1 Month Performance-0.72%8.99%7.38%6.56%
1 Year Performance-23.43%12.97%63.13%28.27%

Illumina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
4.8453 of 5 stars
$96.68
-2.7%
$123.06
+27.3%
-20.4%$14.87B$4.37B12.249,030Positive News
A
Agilent Technologies
4.6733 of 5 stars
$128.13
-0.5%
$139.25
+8.7%
-8.5%$36.32B$6.51B30.0817,900Positive News
MTD
Mettler-Toledo International
4.3033 of 5 stars
$1,314.38
+0.7%
$1,311.11
-0.2%
-7.8%$27.08B$3.87B33.2817,300Positive News
WAT
Waters
4.8102 of 5 stars
$309.58
+1.1%
$378.73
+22.3%
-7.3%$18.43B$2.96B27.927,600
TECH
Bio-Techne
4.9902 of 5 stars
$54.11
-0.6%
$70.42
+30.1%
-27.6%$8.48B$1.22B117.633,100Positive News
CRL
Charles River Laboratories International
4.5881 of 5 stars
$161.97
-1.2%
$175.69
+8.5%
-17.5%$7.97B$4.05B-121.7820,100Positive News
Analyst Upgrade
BIO
Bio-Rad Laboratories
4.623 of 5 stars
$290.32
-1.7%
$333.50
+14.9%
-10.4%$7.86B$2.57B24.757,700Positive News
BRKR
Bruker
4.9652 of 5 stars
$30.80
-0.1%
$51.30
+66.6%
-49.9%$4.67B$3.37B59.2311,396Short Interest ↑
PACB
Pacific Biosciences of California
2.7331 of 5 stars
$1.25
-1.6%
$1.90
+52.0%
-25.0%$375.46M$154.01M-0.55730Positive News
HBIO
Harvard Bioscience
3.9564 of 5 stars
$0.45
-4.9%
$3.00
+559.9%
-84.3%$20.24M$94.14M-0.35490Analyst Forecast
Short Interest ↑
TMO
Thermo Fisher Scientific
4.9749 of 5 stars
$487.11
-1.1%
$589.38
+21.0%
-20.6%$183.94B$42.88B28.17125,000Trending News
Analyst Upgrade
Insider Trade
Analyst Revision

Related Companies and Tools


This page (NASDAQ:ILMN) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners